Shelter Pharma Past Earnings Performance
Past criteria checks 5/6
Shelter Pharma has been growing earnings at an average annual rate of 55.5%, while the Pharmaceuticals industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 16.1% per year. Shelter Pharma's return on equity is 19.8%, and it has net margins of 16.9%.
Key information
55.5%
Earnings growth rate
52.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 16.1% |
| Return on equity | 19.8% |
| Net Margin | 16.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Shelter Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 384 | 65 | 11 | 0 |
| 30 Jun 23 | 373 | 61 | 10 | 0 |
| 31 Mar 23 | 362 | 58 | 9 | 0 |
| 31 Mar 22 | 301 | 18 | 8 | 0 |
| 31 Mar 21 | 225 | -2 | 8 | 0 |
| 31 Mar 20 | 301 | 1 | 6 | 0 |
| 31 Mar 19 | 277 | 1 | 6 | 0 |
| 31 Mar 18 | 315 | 1 | 7 | 0 |
| 31 Mar 17 | 300 | 0 | 6 | 0 |
Quality Earnings: 543963 has high quality earnings.
Growing Profit Margin: 543963's current net profit margins (16.9%) are higher than last year (11.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543963's earnings have grown significantly by 55.5% per year over the past 5 years.
Accelerating Growth: 543963's earnings growth over the past year (70%) exceeds its 5-year average (55.5% per year).
Earnings vs Industry: 543963 earnings growth over the past year (70%) exceeded the Pharmaceuticals industry 23.3%.
Return on Equity
High ROE: 543963's Return on Equity (19.8%) is considered low.